Literature DB >> 5328145

The significance of antinuclear factors in rheumatoid arthritis.

J J Condemi, E V Barnett, E C Atwater, R F Jacox, E S Mongan, J H Vaughan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5328145     DOI: 10.1002/art.1780080607

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

1.  Antinuclear factor in rheumatoid arthritis and related diseases.

Authors:  D A Pitkeathly; G Taylor
Journal:  Ann Rheum Dis       Date:  1967-01       Impact factor: 19.103

2.  A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides.

Authors:  R N MacSween; T G Dalakos; M K Jasani; J A Boyle; W W Buchanan; R B Goudie
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

3.  Immunofluorescent patterns and specificity of human antinuclear antibodies.

Authors:  Y B Bickel; E V Barnett; C M Pearson
Journal:  Clin Exp Immunol       Date:  1968-09       Impact factor: 4.330

4.  Antinuclear factors.

Authors: 
Journal:  Br Med J       Date:  1967-06-10

5.  A clinical and serological study of rheumatoid arthritis.

Authors:  M Corbett; J M Downes; F R Schmid
Journal:  Ann Rheum Dis       Date:  1967-11       Impact factor: 19.103

6.  Catabolism and synovial transport of rheumatoid factor.

Authors:  R Bluestone; A Cracchiolo; L S Goldberg; C M Pearson
Journal:  Ann Rheum Dis       Date:  1970-01       Impact factor: 19.103

7.  Value of test for antinuclear antibodies in rheumatic diseases.

Authors:  M M Steven; L G Teh; L S Teh; T Pullar; J J Belch; D Lewis; J Parker; A Zoma
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-09

8.  Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.

Authors:  A A Borg; M J Davis; P T Dawes; M F Shadforth
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.